Leerink Partners Reiterates Outperform Rating on IDEXX Laboratories (IDXX)
Tweet Send to a Friend
Leerink Partners analyst Daniel Clark reiterated an Outperform rating and $580.00 price target on IDEXX Laboratories (NASDAQ: IDXX).The analyst comments ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


